Ruiz-Ruiz Francisco, Menéndez-Orenga Miguel, Medrano Francisco J, Calderón Enrique J, Lora-Pablos David, Navarro-Puerto Maria Asunción, Rodríguez-Torres Patricia, Gómez de la Cámara Agustín
Department of Internal Medicine, Quiron Hospital, Seville, Spain.
Research Institute, Clinical Research Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
Clin Epidemiol. 2019 Jul 22;11:615-624. doi: 10.2147/CLEP.S206017. eCollection 2019.
Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompensated HF: PREDICE and AHEAD. The secondary aim was to evaluate in our setting the changes in the clinical pattern of HF in the last decade in patients hospitalized for a first episode of the disease.
A prospective multicenter cohort study, which included 180 patients hospitalized with "de novo" HF was conducted to validate the PREDICE score. Calibration and discrimination measurements were calculated for the PREDICE model and the PREDICE score (using the validation cohort of the PREDICE) and the AHEAD score (using both the development and the validation cohort of the PREDICE).
For the PREDICE models, the area under the curve (AUC) was 0.68 (95% confidence interval [CI]: 0.57-0.79) and the calibration slope 0.65 (95% CI: 0.21-1.20). For the PREDICE score AUC was 0.59 (95% CI: 0.47-0.71) and slope 0.42 (95% CI: -0.20-1.17). For the AHEAD score the AUC was 0.68 (95% CI: 0.62-0.73) and slope 1.38 (95% CI: 0.62-0.73) when used the development cohort of PREDICE and the AUC was 0.58 (95% CI: 0.49-0.67), and slope 0.68 (95% CI: -0.06 to 1.47) when used its validation cohort.
The present study shows that the two risk scores available for patients with primo-hospitalization for decompensated HF (PREDICE and AHEAD) are not currently valid for predicting mortality at one-year. In our setting the clinical spectrum of hospitalized patients with new-onset HF has been modified over time. The study underscores the need to validate the prognostic models before clinical implementation.
心力衰竭(HF)是一种慢性、常见且使人衰弱的疾病,但病程具有可调节性,改善潜力巨大。本研究旨在验证两种现有的用于首次因失代偿性HF住院患者一年死亡率的临床预测规则:PREDICE和AHEAD。次要目的是评估在我们的研究环境中,过去十年因首次发作该疾病住院的HF患者临床模式的变化。
进行了一项前瞻性多中心队列研究,纳入180例“新发”HF住院患者以验证PREDICE评分。计算PREDICE模型以及PREDICE评分(使用PREDICE的验证队列)和AHEAD评分(使用PREDICE的开发队列和验证队列)的校准和区分度测量值。
对于PREDICE模型,曲线下面积(AUC)为0.68(95%置信区间[CI]:0.57 - 0.79),校准斜率为0.65(95% CI:0.21 - 1.20)。对于PREDICE评分,AUC为0.59(95% CI:0.47 - 0.71),斜率为0.42(95% CI: - 0.20 - 1.17)。对于AHEAD评分,使用PREDICE的开发队列时,AUC为0.68(95% CI:0.62 - 0.73),斜率为1.38(95% CI:0.62 - 0.73);使用其验证队列时,AUC为0.58(95% CI:0.49 - 0.67),斜率为0.68(95% CI: - 0.06至1.47)。
本研究表明,现有的两种用于首次因失代偿性HF住院患者的风险评分(PREDICE和AHEAD)目前对于预测一年死亡率无效。在我们的研究环境中,新发HF住院患者的临床谱随时间发生了改变。该研究强调在临床应用前验证预后模型的必要性。